Barclays Reiterates an 'Overweight' on Covidien Ltd (COV); Adjusting Numbers on Recall Issue
Tweet Send to a Friend
Barclays reiterates an 'Overweight' on Covidien Ltd (NYSE: COV) price target of $62.00.
Analyst, Matthew Taylor, said, "COV announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Matthew Taylor, said, "COV announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
